Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 ( 5 mg,
10 mg, 20 mg and 40 mg ) in Healthy Young Male Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau